The feasibility of pelvic floor therapies to treat pelvic floor dysfunction in women following surgery for gynaecological cancer: a telehealth intervention trial

niversity of Melbourne0 个研究点目标入组 36 人开始时间: 2021年7月8日最近更新: 2023年2月13日

适应症

试验速览

暂无简介。

•Women who have had surgery for primary gynaecological treatment for uterine, endometrial, cervical or ovarian cancer, based on oncology assessment, or a histologically confirmed uterine, endometrial, cervical or ovarian tumour, International Federation of Gynecology and Obstetrics (FIGO) cancer staging system classification stages I-III (if known); have any type of urinary and/or faecal incontinence, have an Eastern Cooperative Oncology Group performance status of between 0-2 (with a score of 0 being fully active to and a score of 2 being resting in bed less than 50% of the day); have the capability and access to use a telecommunication platform in their own home; have sufficient English language skills to participate; and are at least 18 years of age.

•Women with a FIGO cancer staging system classification stage IV, who are pregnant, up to 12 months postnatal or who are breastfeeding, have neurological disorders or severe physical/psychiatric impairments, or who have, within the last 2 years, received physiotherapist-supervised PFMT or pelvic surgery for incontinence or pelvic organ prolapse will be excluded.

发起方

niversity of Melbourne